Ballentine Partners, LLC Pacific Biosciences Of California, Inc. Transaction History
Ballentine Partners, LLC
- $5.74 Billion
- Q1 2025
A detailed history of Ballentine Partners, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 19,019 shares of PACB stock, worth $21,111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,019
Previous 29,152
34.76%
Holding current value
$21,111
Previous $53,000
58.49%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PACB
# of Institutions
262Shares Held
254MCall Options Held
3.05MPut Options Held
1.71M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.5MShares$40.5 Million0.46% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$26.2 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$26 Million8.16% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.3MShares$23.7 Million0.68% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$22.7 Million0.17% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $250M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...